Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Low myo-inositol indicating astrocytic damage in a case series of NMO.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Brain functional plasticity at rest and during action in multiple sclerosis patients.
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent.
Fatigue in multiple sclerosis: a look at the role of poor sleep.
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Pharmacology and Structure of P2Y Receptors.
Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
Chronic stress regulates NG2(+) cell maturation and myelination in the prefrontal cortex through induction of death receptor 6.
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis.
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.
Pages
« first
‹ previous
…
613
614
615
616
617
618
619
620
621
…
next ›
last »